Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer

Journal of Thoracic Oncology

Volumn 10, Issue 12, 2015, Pages 1795-1799

  Kim, Eun Young ^a   Kim, Young Saing ^b   Park, Inkeun ^b   Ahn, Hee Kyung ^b   Cho, Eun Kyung ^b   Jeong, Yu Mi ^a  

^a Department of Radiology ^*  (United States)

^b Gachon University   (South Korea)

Author keywords

Prognosis; Sarcopenia; Skeletal muscle; Small cell lung cancer; Tomography; X ray computed

Indexed keywords

FLUORODEOXYGLUCOSE; LACTATE DEHYDROGENASE;

AGED; ARTICLE; BODY MASS; CACHEXIA; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL FEATURE; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LACTATE DEHYDROGENASE BLOOD LEVEL; LUMBAR VERTEBRA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PET-CT SCANNER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOPENIA; SMALL CELL LUNG CANCER; SURVIVAL PREDICTION; DIAGNOSTIC IMAGING; LUNG TUMOR; PATHOLOGY; PROCEDURES; PROGNOSIS; X-RAY COMPUTED TOMOGRAPHY;

AGED; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SARCOPENIA; SMALL CELL LUNG CARCINOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84948099104     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000690     Document Type: Article

References (23)

1. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
2. Govindan R, Page N, Morgensztern D, et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: Analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 2006;24:4539-4544.
3. Fruh M, De Ruysscher D, Popat S, et al. Small-cell lung cancer (SCLC): ESMO clinical practice guidelines for diagnosis, treatment and followup. Ann Oncol 2013;24(Suppl 6):vi99-105.
4. Morabito A, Carillio G, Daniele G, et al. Treatment of small cell lung cancer. Crit Rev Oncol Hematol 2014;91:257-270.
5. Ross PJ, Ashley S, Norton A, et al. Do patients with weight loss have a worse outcome when undergoing chemotherapy for lung cancers Br J Cancer 2004;90:1905-1911.
6. Baracos VE, Reiman T, Mourtzakis M, et al. Body composition in patients with non-small cell lung cancer: A contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010;91:1133S-1137S.
7. Collins J, Noble S, Chester J, et al. The assessment and impact of sarcopenia in lung cancer: A systematic literature review. BMJ Open 2014;4:e003697.
8. Huillard O, Mir O, Peyromaure M, et al. Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients. Br J Cancer 2013;108:1034-1041.
9. Harimoto N, Shirabe K, Yamashita YI, et al. Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013;100:1523-1530.
10. Prado CM, Baracos VE, McCargar LJ, et al. Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009;15:2920-2926.
11. Villasenõr A, Ballard-Barbash R, Baumgartner K, et al. Prevalence and prognostic effect of sarcopenia in breast cancer survivors: The HEAL Study. J Cancer Surviv 2012;6:398-406.
12. Fukushima H, Yokoyama M, Nakanishi Y, Tobisu K, Koga F. Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma. PLoS One 2015;10:e0115895.
13. Meza-Junco J, Montano-Loza AJ, Baracos VE, et al. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma. J Clin Gastroenterol 2013;47:861-870.
14. Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: An international consensus. Lancet Oncol 2011;12:489-495.
15. Consultation WHOE. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004;363:157-163.
16. Kalemkerian GP, Gadgeel SM. Modern staging of small cell lung cancer. J Natl Compr Canc Netw 2013;11:99-104.
17. Song MY, Ruts E, Kim J, et al. Sarcopenia and increased adipose tissue infiltration of muscle in elderly African American women. Am J Clin Nutr 2004;79:874-880.
18. Mourtzakis M, Prado CM, Lieffers JR, et al. A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 2008;33:997-1006.
19. Kim YS, Lee Y, Chung YS, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 2012;67:1107-1113.
20. Rosenberg I. Summary comments: epidemiological and methodological problems in determining nutritional status of older persons. Am J Clin Nutr 1989;50:1231-1233.
21. Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci 2000;904:437-448.
22. Prado CM, Lieffers JR, McCargar LJ, et al. Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol 2008;9:629-635.
23. Sayer AA, Robinson SM, Patel HP, et al. New horizons in the pathogenesis, diagnosis and management of sarcopenia. Age Ageing 2013;42:145-150.